AAAAAA
Results:
1-15
|
Results: 15
Authors:
O'Neill, S
Ekstrom, L
Lastowska, M
Roberts, P
Brodeur, GM
Kees, UR
Schwab, M
Bown, N
Citation: S. O'Neill et al., MYCN amplification and 17q in neuroblastoma: Evidence for structural association, GENE CHROM, 30(1), 2001, pp. 87-90
Authors:
Lastowska, M
Cullinane, C
Variend, S
Cotterill, S
Bown, N
O'Neill, S
Mazzocco, K
Roberts, P
Nicholson, J
Ellershaw, C
Pearson, ADJ
Jackson, MS
Citation: M. Lastowska et al., Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors, J CL ONCOL, 19(12), 2001, pp. 3080-3090
Authors:
Vandesompele, J
Speleman, F
Van Roy, N
Laureys, C
Brinkschmidt, C
Christiansen, H
Lampert, F
Lastowska, M
Bown, N
Pearson, A
Nicholson, JC
Ross, F
Combaret, V
Delattre, O
Feuerstein, BC
Plantaz, D
Citation: J. Vandesompele et al., Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?, MED PED ONC, 36(1), 2001, pp. 5-10
Authors:
Bown, N
Lastowska, M
Cotterill, S
O'Neill, S
Ellershaw, C
Roberts, P
Lewis, L
Pearson, ADJ
Citation: N. Bown et al., 17q gain in neuroblastoma predicts adverse clinical outcome, MED PED ONC, 36(1), 2001, pp. 14-19
Authors:
Lastowska, M
Van Roy, N
Bown, N
Speleman, F
Roberts, P
Lunec, J
Strachan, T
Pearson, ADJ
Jackson, MS
Citation: M. Lastowska et al., Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 20-23
Authors:
Wells, AW
Bown, N
Reid, MM
Hamilton, PJ
Jackson, GH
Taylor, PR
Citation: Aw. Wells et al., Erythroleukaemia in the north of England: a population based study, J CLIN PATH, 54(8), 2001, pp. 608-612
Authors:
Plantaz, D
Vandesompele, J
Van Roy, N
Lastowska, M
Bown, N
Combaret, V
Favrot, MC
Delattre, O
Michon, J
Benard, J
Hartmann, O
Nicholson, JC
Ross, FM
Brinkschmidt, C
Laureys, G
Caron, H
Matthay, KK
Feuerstein, BG
Speleman, F
Citation: D. Plantaz et al., Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification, INT J CANC, 91(5), 2001, pp. 680-686
Authors:
Tweddle, DA
Malcolm, AJ
Bown, N
Pearson, ADJ
Lunec, J
Citation: Da. Tweddle et al., Evidence for the development of p53 mutations after cytotoxic therapy in aneuroblastoma cell line, CANCER RES, 61(1), 2001, pp. 8-13
Authors:
Cuthbert, G
Thompson, K
Breese, C
McCullough, S
Bown, N
Citation: G. Cuthbert et al., Sensitivity of FISH in detection of MLL translocations, GENE CHROM, 29(2), 2000, pp. 180-185
Authors:
Cuthbert, G
Thompson, K
McCullough, S
Watmore, A
Dickinson, H
Telford, N
Mugneret, F
Harrison, C
Griffiths, M
Bown, N
Citation: G. Cuthbert et al., MLL amplification in acute leukaemia: a United Kingdom Cancer CytogeneticsGroup (UKCCG) study, LEUKEMIA, 14(11), 2000, pp. 1885-1891
Authors:
Freeman-Edward, J
O'Neill, S
Lastowska, M
Bown, N
Citation: J. Freeman-edward et al., Expulsion of amplified MYCN from neuroblastoma tumor cells, CANC GENET, 116(1), 2000, pp. 87-88
Authors:
Abrams, D
Marques, JM
Bown, N
Henson, M
Citation: D. Abrams et al., Pro-norm and anti-norm deviance within and between groups, J PERS SOC, 78(5), 2000, pp. 906-912
Authors:
Speleman, F
Bown, N
Citation: F. Speleman et N. Bown, 17q gain in neuroblastoma, NEUROBLASTOMA, 2000, pp. 113-124
Authors:
Cuthbert, G
McCullough, S
Finney, R
Breese, G
Bown, N
Citation: G. Cuthbert et al., Jumping translocation at IIq23 with MLL gene rearrangement and interstitial telomeric sequences, GENE CHROM, 24(4), 1999, pp. 295-298
Authors:
Bown, N
Cotterill, S
Lastowska, M
O'Neill, S
Pearson, ADJ
Plantaz, D
Meddeb, M
Danglot, G
Brinkschmidt, C
Christiansen, H
Laureys, G
Speleman, F
Citation: N. Bown et al., Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma, N ENG J MED, 340(25), 1999, pp. 1954-1961
Risultati:
1-15
|